Robotic-Assisted Versus Conventional Total Knee Arthroplasty With Virtual Home-Based Rehabilitation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorMark Hurworth

About this trial

The goal of this clinical trial is to learn whether robotic-assisted total knee replacement improves recovery compared with conventional total knee replacement in adults with knee osteoarthritis when both groups follow the same structured home-based rehabilitation program. Robotic-assisted and conventional (non-robotic) total knee replacement are both widely used as part of routine clinical care. This study will compare recovery during the first six weeks after surgery.

The main questions the study aims to answer are:

1. Does robotic-assisted total knee replacement improve knee pain and knee function six weeks after surgery compared with conventional total knee replacement? 2. Does robotic-assisted surgery improve physical function, walking ability, leg strength, quality of life, and participants' experience of rehabilitation? 3. Are there any differences in recovery, length of hospital stay, or safety between the two surgical approaches?

Researchers will compare robotic-assisted total knee replacement with conventional total knee replacement. Both groups will complete the same rehabilitation program before and after surgery so that any differences in recovery are more likely to be related to the type of surgery rather than differences in rehabilitation.

Participants will:

* Be randomly assigned (by chance, similar to flipping a coin) to receive either robotic-assisted or conventional total knee replacement surgery. * Complete a structured rehabilitation program that includes education and exercises during the four weeks before surgery and a home-based exercise program for six weeks after surgery. * Use a study-provided seated exercise bike, receive support from a physiotherapist through telehealth appointments, secure messaging, and home visits where required, and use a digital application to guide the rehabilitation program and record exercise completion and symptoms. * Complete questionnaires about knee pain, knee function, general health, quality of life, and satisfaction with the rehabilitation program. * Attend study assessments before surgery, immediately before surgery after completing the pre-surgery program, and about six weeks after surgery. These assessments include simple physical activities such as standing up from a chair, walking, cycling, and measuring leg strength. * Allow information about their surgery and hospital stay, such as the duration of surgery and the number of nights spent in hospital, to be recorded for the study.

The results of this study will help researchers understand whether robotic-assisted total knee replacement provides additional benefits over conventional total knee replacement when both are combined with the same structured home-based rehabilitation program. The findings may help patients, healthcare professionals, and health services make informed decisions about the use of robotic-assisted knee replacement surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 40 years or older.

Knee osteoarthritis confirmed by clinical assessment and imaging (e.g., X-ray or MRI) requiring primary total knee replacement surgery.

Scheduled to undergo primary total knee arthroplasty with one of the participating surgeons at St John of God Murdoch Hospital.

Able to understand the study requirements and provide written informed consent.

Disqualifiers

Unable to understand English sufficiently to provide informed consent, complete study questionnaires, or safely follow the rehabilitation program.

Previous major surgery on the leg undergoing knee replacement (for example, revision knee replacement or high tibial osteotomy).

Osteoarthritis caused by another medical condition (for example, inflammatory arthritis, previous joint infection, gout, fracture involving the joint, congenital abnormality, or haemochromatosis).

Chronic pain unrelated to the knee being replaced that could affect study assessments.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Robotic-assisted Total Knee Arthroplasty

    Procedure/Surgery

    Primary total knee arthroplasty performed using an approved robotic-assisted surgical system by an experienced orthopaedic surgeon. Robotic assistance is used for pre-operative planning and/or intra-operative execution of bone resections and component positioning in accordance with the manufacturer's instructions for use and the surgeon's standard clinical practice.

  • Conventional Total Knee Arthroplasty

    Procedure/Surgery

    Primary total knee arthroplasty performed using conventional manual instrumentation without robotic assistance by an experienced orthopaedic surgeon. Surgical technique follows standard clinical practice.

  • Hybrid Virtually-Assisted Peri-operative Rehabilitation Program

    Behavioral

    A standardized hybrid virtually-assisted comprehensive peri-operative care program delivered before and after surgery. The program comprises a 4-week pre-operative preparation phase followed by a 6-week post-operative rehabilitation phase. It includes patient education, home-based cycling and non-cycling exercises, telehealth consultations, tele-messaging support, remote monitoring, limited in-person physiotherapy services, and symptom-contingent, rule-based exercise progression. The program is delivered identically to both study groups using standardized, protocol-defined procedures.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Robotic-assisted Total Knee ArthroplastyExperimental treatment 2 interventions
Group B: Conventional Total Knee ArthroplastyActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Oxford Knee Score (OKS), a composite patient-reported outcome measure of knee-related pain and functional limitation.

Oxford Knee Score questionnaire (validated 12-item patient-reported outcome measure assessing knee-related pain and functional limitation, combined into a single score ranging from 0 to 48, with higher scores indicating better knee-related health status).

Time frame
Baseline (4 weeks pre-operative), pre-surgery (after completion of the pre-operative program), and 6 weeks post-surgery.

Secondary outcomes

1

Adherence to the virtual comprehensive care program

Adherence will be defined as the proportion of prescribed exercise sessions completed over the intervention period, based on session completion logs recorded in the digital rehabilitation platform and study-specific database. Additional data captured by the platform, including cycling metrics (e.g., cadence and power output) and participant-reported pain and perceived exertion, will be used to support physiotherapist monitoring and exercise progression but are not included in the calculation of adherence.

Time frame
Continuously throughout the peri-operative program via the digital platform and summarised weekly (pre-operative weeks 1-4 and post-operative weeks 1-6), with a final cumulative adherence value at 6 weeks post-surgery.
2

Program completion of the virtual comprehensive care program

Program completion will be determined from records within the digital rehabilitation platform and study-specific database, defined as participation through the full intervention period (4-week pre-operative and 6-week post-operative phases), as documented by session completion logs and physiotherapist records.

Time frame
Assessed at completion of the peri-operative program (6 weeks post-surgery).
3

Tourniquet time

Provided by the operating surgeon and recorded in the study database using the participant's study identification code.

Time frame
During the total knee arthroplasty procedure.
4

Hospital length of stay

Hospital length of stay, measured in days from hospital admission to hospital discharge for the index admission for total knee arthroplasty, provided by the operating surgeon and recorded in the study database.

Time frame
From hospital admission until hospital discharge, assessed up to 30 days.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mark Hurworth

Lead sponsor

Orthoworth Pty Ltd

Sponsor institution

Curtin University

Collaborator

Johnson & Johnson Medical Companies

Collaborator

This trial is not recruiting at the moment. You can still explore other options: